CMDT & Nursing Clinical
Mastery Master Test
Bank
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Critical Action" Cheat Sheet (2026/2027 Redline Metrics)
● PART II: THE ELITE TEST BANK
○ Questions 1–28: Foundational Syntax & Application (Core Definitions &
Protocol Verification)
○ Questions 29–58: Professional Simulation (Immediate Actions & Shifting
Variables)
○ Questions 59–88: Grandmaster Synthesis (High-Stakes, Multi-System Crises)
PART I: THE PRIMER
You are no longer a student hoping to pass; you are a professional preparing to dictate
outcomes. Using this test bank will systematically dismantle your reliance on outdated legacy
practices and forge the active, anti-fragile intuition required for 2026/2027 clinical and regulatory
dominance. We do not memorize here; we engineer clinical certainty.
The "Critical Action" Cheat Sheet (2026 Redline):
Domain 2026/2027 Clinical Standard Rationale
AHA Stroke Tenecteplase (TNK) 0.25 mg/kg Replaces 60-min Alteplase
single bolus. infusion. Maintain BP
<180/105; never target <140
intensively.
AHA/ACC Risk PREVENT Calculator (10 & Replaces Pooled Cohort
30-year risk). Equations. Integrates UACR,
HbA1c, and SDI for CKM
staging.
AASLD Renal Terlipressin in HRS-AKI limits. Avoid if Cr >5.0 or ACLF Grade
3. High afterload + albumin
preload triggers fatal pulmonary
edema.
ADA Diabetes Retatrutide & Perioperative Retatrutide is a triple agonist
SGLT2i. (GIP/GLP-1/Glucagon). SGLT2i
must be stopped 3-4 days
,Domain 2026/2027 Clinical Standard Rationale
pre-op to avert euglycemic
DKA.
Texas BON Rule 217.11(1)(T) & Safe Accept only safe assignments.
Harbor. Your license is your liability.
"Operation Nightingale"
mandates strict credential
verification.
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: A 68-year-old client presents with acute ischemic stroke (AIS) within 2.5 hours of symptom
onset. The practitioner prepares for intravenous thrombolysis. According to 2026 AHA
guidelines, which administration protocol is the MOST APPROPRIATE? A) Alteplase 0.9 mg/kg,
with 10% as a bolus and the remainder over 60 minutes. B) Tenecteplase 0.25 mg/kg
administered as a single 5-10 second IV bolus. C) Tenecteplase 0.40 mg/kg administered as a
continuous infusion over 30 minutes. D) Alteplase 0.9 mg/kg administered as a single rapid IV
push.
● The Answer: B (Tenecteplase 0.25 mg/kg administered as a single 5-10 second IV
bolus.)
● Distractor Analysis:
○ A is incorrect: While technically an option, TNK is favored for ease of use, and the
question demands the 2026 standard bolus update focus.
○ C is incorrect: TNK is not given as a continuous infusion or at 0.40 mg/kg for AIS.
○ D is incorrect: Alteplase is never given as a single rapid IV push; doing so causes
catastrophic bleeding.
The Mentor's Analysis: Time is brain. Tenecteplase (TNK) replaces the cumbersome
60-minute alteplase infusion with a single, rapid 5-10 second push. This drastically reduces
nursing resource intensity and expedites door-to-needle times.
Q2: Following the administration of Tenecteplase for AIS, the client's blood pressure reads
165/95 mm Hg. The receiving nurse asks if an IV antihypertensive drip should be initiated to
drive the systolic BP below 140 mm Hg. What is the MOST APPROPRIATE response? A)
Initiate the drip; 2026 AHA guidelines require intensive lowering to <140 mm Hg to prevent
hemorrhagic conversion. B) Do not initiate the drip; maintain BP strictly <180/105 mm Hg, as
intensive lowering does not improve outcomes and may cause harm. C) Administer a fluid bolus
to ensure adequate cerebral perfusion pressure. D) Initiate the drip only if the client exhibits
signs of increased intracranial pressure.
● The Answer: B (Do not initiate the drip; maintain BP strictly <180/105 mm Hg...)
● Distractor Analysis:
○ A is incorrect: This represents an outdated legacy hypothesis definitively debunked
in 2026 guidelines.
○ C is incorrect: Fluid boluses are contraindicated in an already hypertensive stroke
patient.
○ D is incorrect: BP control post-thrombolytic has strict numerical targets independent
of ICP signs.
The Mentor's Analysis: The penumbra requires perfusion. Intensive BP lowering (<140 mm
,Hg) starves ischemic brain tissue and worsens functional outcomes. The hard deck
post-thrombolytic is simply <180/105 mm Hg.
Q3: A 45-year-old male with a BMI of 34 and type 2 diabetes asks about the new "triple
hormone" medication for weight loss and A1C control. The practitioner is discussing Retatrutide.
Which receptor mechanism BEST defines this agent per ADA 2026 standards? A) GLP-1 and
GIP dual agonism. B) GLP-1, GIP, and Glucagon receptor agonism. C) SGLT2, GLP-1, and
DPP-4 inhibition. D) Selective Thyroid Hormone Receptor-beta (THR-β) agonism.
● The Answer: B (GLP-1, GIP, and Glucagon receptor agonism.)
● Distractor Analysis:
○ A is incorrect: This describes Tirzepatide, not Retatrutide.
○ C is incorrect: This is an invented combination of discrete drug classes.
○ D is incorrect: This describes Resmetirom, used for MASH.
The Mentor's Analysis: Retatrutide is the "Triple G" agonist. The addition of glucagon receptor
agonism to GIP and GLP-1 increases hepatic glucose output transiently but drives massive
energy expenditure, leading to unprecedented weight loss (up to 16.8%) and A1C reduction.
Q4: A primary care clinic transitions from the Pooled Cohort Equations (PCE) to the AHA 2026
PREVENT calculator. Which novel data points are now REQUIRED or highly suggested to
personalize this new cardiovascular risk assessment? A) High-sensitivity CRP and
homocysteine levels. B) Left ventricular ejection fraction and BNP. C) Urine albumin-creatinine
ratio (UACR), HbA1c, and Social Deprivation Index (SDI). D) Coronary artery calcium (CAC)
score and resting heart rate.
● The Answer: C (Urine albumin-creatinine ratio (UACR), HbA1c, and Social Deprivation
Index (SDI).)
● Distractor Analysis:
○ A is incorrect: These are inflammatory markers, not the core additions to the
PREVENT equation.
○ B is incorrect: PREVENT explicitly excludes patients with known severe subclinical
CVD (e.g., LVEF <40%).
○ D is incorrect: CAC is a risk enhancer, not a core variable of the PREVENT
calculator.
The Mentor's Analysis: Cardiovascular, Kidney, and Metabolic (CKM) health are inextricably
linked. PREVENT integrates renal (UACR) and metabolic (HbA1c) metrics with social
determinants (SDI) to forecast both 10-year and 30-year risks, catching systemic failure
decades before a myocardial infarction.
Q5: An adult client with decompensated cirrhosis and hepatorenal syndrome-acute kidney injury
(HRS-AKI) is prescribed terlipressin. The client's baseline serum creatinine is 5.4 mg/dL. What
is the FIRST action the practitioner should take? A) Administer the terlipressin via rapid IV bolus
to ensure immediate splanchnic vasoconstriction. B) Withhold the terlipressin and consult the
hepatologist, as efficacy is limited and risks outweigh benefits at this creatinine level. C)
Co-administer a high-dose albumin infusion (100g) rapidly to maximize oncotic pressure. D)
Prepare the client for immediate hemodialysis prior to terlipressin administration.
● The Answer: B (Withhold the terlipressin and consult the hepatologist, as efficacy is
limited and risks outweigh benefits at this creatinine level.)
● Distractor Analysis:
○ A is incorrect: Terlipressin is preferred as a continuous infusion to mitigate
respiratory failure, not a rapid bolus.
○ C is incorrect: High-dose albumin combined with terlipressin severely exacerbates
fluid overload and respiratory failure risk.
, ○ D is incorrect: Dialysis does not change the contraindication profile of terlipressin.
The Mentor's Analysis: The FDA label explicitly limits terlipressin use when baseline serum
creatinine is >5.0 mg/dL. At this threshold, renal recovery is highly unlikely, and the risk of fatal
respiratory failure from increased cardiac afterload is unjustified.
Q6: A 76-year-old client is scheduled for discharge. According to CDC/ACIP 2026/2027
guidelines, which statement regarding the RSV vaccine is MOST ACCURATE? A) "You will
need to receive this vaccine annually, alongside your influenza shot." B) "Because you received
the RSV vaccine last year, you are due for your booster today." C) "Since you are over 75, you
should receive a single lifetime dose; no booster is currently recommended." D) "The vaccine is
only indicated if you have a history of chronic obstructive pulmonary disease."
● The Answer: C ("Since you are over 75, you should receive a single lifetime dose; no
booster is currently recommended.")
● Distractor Analysis:
○ A is incorrect: RSV is currently not an annual vaccine.
○ B is incorrect: No boosters are recommended if the patient was previously
vaccinated.
○ D is incorrect: Age >=75 is a universal indication regardless of comorbidities.
The Mentor's Analysis: Do not conflate RSV protocols with influenza or COVID-19. The RSV
vaccine (Arexvy, Abrysvo, mResvia) provides sustained protection and is strictly a single-dose
administration for the 2026/2027 cycle.
Q7: Under Texas Board of Nursing Rule 217.11, a nurse refuses an assignment to float to the
neonatal intensive care unit (NICU), citing a lack of training and experience. The supervisor
threatens termination. Which principle STRICTLY protects the nurse's license in this scenario?
A) Rule 217.11(1)(B) regarding maintaining a safe environment supersedes employer directives.
B) The nurse cannot be terminated under the Texas At-Will Employment Doctrine. C) The
physician's order dictates staffing, nullifying the supervisor's threat. D) The nurse must accept
the assignment but file an incident report retroactively.
● The Answer: A (Rule 217.11(1)(B) regarding maintaining a safe environment supersedes
employer directives.)
● Distractor Analysis:
○ B is incorrect: The BON does not govern employment law; a nurse can be fired, but
their license is protected by refusing an unsafe assignment.
○ C is incorrect: Physicians do not dictate nursing assignments.
○ D is incorrect: Accepting an assignment you are incompetent to perform
immediately makes you liable for patient harm (Rule 217.11(1)(T)).
The Mentor's Analysis: Your license, your liability. The Board mandates you accept only
assignments commensurate with your education and ability. You must invoke Safe Harbor
before accepting the assignment. Employer threats do not shield you from Board discipline if a
patient dies under your incompetent care.
Q8: An APRN delegates the management of a complex, unstable patient on a titrated
vasoactive drip to a newly licensed LVN. According to Texas BON delegation rules, what is the
fundamental flaw in this action? A) Vasoactive drips must only be managed by physicians. B)
APRNs cannot assign tasks to LVNs that exceed the LVN's scope of practice, even with a
co-signature. C) The APRN failed to secure written consent from the patient for the delegation.
D) LVNs are strictly prohibited from working in intensive care units.
● The Answer: B (APRNs cannot assign tasks to LVNs that exceed the LVN's scope of
practice, even with a co-signature.)
● Distractor Analysis:
Mastery Master Test
Bank
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Critical Action" Cheat Sheet (2026/2027 Redline Metrics)
● PART II: THE ELITE TEST BANK
○ Questions 1–28: Foundational Syntax & Application (Core Definitions &
Protocol Verification)
○ Questions 29–58: Professional Simulation (Immediate Actions & Shifting
Variables)
○ Questions 59–88: Grandmaster Synthesis (High-Stakes, Multi-System Crises)
PART I: THE PRIMER
You are no longer a student hoping to pass; you are a professional preparing to dictate
outcomes. Using this test bank will systematically dismantle your reliance on outdated legacy
practices and forge the active, anti-fragile intuition required for 2026/2027 clinical and regulatory
dominance. We do not memorize here; we engineer clinical certainty.
The "Critical Action" Cheat Sheet (2026 Redline):
Domain 2026/2027 Clinical Standard Rationale
AHA Stroke Tenecteplase (TNK) 0.25 mg/kg Replaces 60-min Alteplase
single bolus. infusion. Maintain BP
<180/105; never target <140
intensively.
AHA/ACC Risk PREVENT Calculator (10 & Replaces Pooled Cohort
30-year risk). Equations. Integrates UACR,
HbA1c, and SDI for CKM
staging.
AASLD Renal Terlipressin in HRS-AKI limits. Avoid if Cr >5.0 or ACLF Grade
3. High afterload + albumin
preload triggers fatal pulmonary
edema.
ADA Diabetes Retatrutide & Perioperative Retatrutide is a triple agonist
SGLT2i. (GIP/GLP-1/Glucagon). SGLT2i
must be stopped 3-4 days
,Domain 2026/2027 Clinical Standard Rationale
pre-op to avert euglycemic
DKA.
Texas BON Rule 217.11(1)(T) & Safe Accept only safe assignments.
Harbor. Your license is your liability.
"Operation Nightingale"
mandates strict credential
verification.
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: A 68-year-old client presents with acute ischemic stroke (AIS) within 2.5 hours of symptom
onset. The practitioner prepares for intravenous thrombolysis. According to 2026 AHA
guidelines, which administration protocol is the MOST APPROPRIATE? A) Alteplase 0.9 mg/kg,
with 10% as a bolus and the remainder over 60 minutes. B) Tenecteplase 0.25 mg/kg
administered as a single 5-10 second IV bolus. C) Tenecteplase 0.40 mg/kg administered as a
continuous infusion over 30 minutes. D) Alteplase 0.9 mg/kg administered as a single rapid IV
push.
● The Answer: B (Tenecteplase 0.25 mg/kg administered as a single 5-10 second IV
bolus.)
● Distractor Analysis:
○ A is incorrect: While technically an option, TNK is favored for ease of use, and the
question demands the 2026 standard bolus update focus.
○ C is incorrect: TNK is not given as a continuous infusion or at 0.40 mg/kg for AIS.
○ D is incorrect: Alteplase is never given as a single rapid IV push; doing so causes
catastrophic bleeding.
The Mentor's Analysis: Time is brain. Tenecteplase (TNK) replaces the cumbersome
60-minute alteplase infusion with a single, rapid 5-10 second push. This drastically reduces
nursing resource intensity and expedites door-to-needle times.
Q2: Following the administration of Tenecteplase for AIS, the client's blood pressure reads
165/95 mm Hg. The receiving nurse asks if an IV antihypertensive drip should be initiated to
drive the systolic BP below 140 mm Hg. What is the MOST APPROPRIATE response? A)
Initiate the drip; 2026 AHA guidelines require intensive lowering to <140 mm Hg to prevent
hemorrhagic conversion. B) Do not initiate the drip; maintain BP strictly <180/105 mm Hg, as
intensive lowering does not improve outcomes and may cause harm. C) Administer a fluid bolus
to ensure adequate cerebral perfusion pressure. D) Initiate the drip only if the client exhibits
signs of increased intracranial pressure.
● The Answer: B (Do not initiate the drip; maintain BP strictly <180/105 mm Hg...)
● Distractor Analysis:
○ A is incorrect: This represents an outdated legacy hypothesis definitively debunked
in 2026 guidelines.
○ C is incorrect: Fluid boluses are contraindicated in an already hypertensive stroke
patient.
○ D is incorrect: BP control post-thrombolytic has strict numerical targets independent
of ICP signs.
The Mentor's Analysis: The penumbra requires perfusion. Intensive BP lowering (<140 mm
,Hg) starves ischemic brain tissue and worsens functional outcomes. The hard deck
post-thrombolytic is simply <180/105 mm Hg.
Q3: A 45-year-old male with a BMI of 34 and type 2 diabetes asks about the new "triple
hormone" medication for weight loss and A1C control. The practitioner is discussing Retatrutide.
Which receptor mechanism BEST defines this agent per ADA 2026 standards? A) GLP-1 and
GIP dual agonism. B) GLP-1, GIP, and Glucagon receptor agonism. C) SGLT2, GLP-1, and
DPP-4 inhibition. D) Selective Thyroid Hormone Receptor-beta (THR-β) agonism.
● The Answer: B (GLP-1, GIP, and Glucagon receptor agonism.)
● Distractor Analysis:
○ A is incorrect: This describes Tirzepatide, not Retatrutide.
○ C is incorrect: This is an invented combination of discrete drug classes.
○ D is incorrect: This describes Resmetirom, used for MASH.
The Mentor's Analysis: Retatrutide is the "Triple G" agonist. The addition of glucagon receptor
agonism to GIP and GLP-1 increases hepatic glucose output transiently but drives massive
energy expenditure, leading to unprecedented weight loss (up to 16.8%) and A1C reduction.
Q4: A primary care clinic transitions from the Pooled Cohort Equations (PCE) to the AHA 2026
PREVENT calculator. Which novel data points are now REQUIRED or highly suggested to
personalize this new cardiovascular risk assessment? A) High-sensitivity CRP and
homocysteine levels. B) Left ventricular ejection fraction and BNP. C) Urine albumin-creatinine
ratio (UACR), HbA1c, and Social Deprivation Index (SDI). D) Coronary artery calcium (CAC)
score and resting heart rate.
● The Answer: C (Urine albumin-creatinine ratio (UACR), HbA1c, and Social Deprivation
Index (SDI).)
● Distractor Analysis:
○ A is incorrect: These are inflammatory markers, not the core additions to the
PREVENT equation.
○ B is incorrect: PREVENT explicitly excludes patients with known severe subclinical
CVD (e.g., LVEF <40%).
○ D is incorrect: CAC is a risk enhancer, not a core variable of the PREVENT
calculator.
The Mentor's Analysis: Cardiovascular, Kidney, and Metabolic (CKM) health are inextricably
linked. PREVENT integrates renal (UACR) and metabolic (HbA1c) metrics with social
determinants (SDI) to forecast both 10-year and 30-year risks, catching systemic failure
decades before a myocardial infarction.
Q5: An adult client with decompensated cirrhosis and hepatorenal syndrome-acute kidney injury
(HRS-AKI) is prescribed terlipressin. The client's baseline serum creatinine is 5.4 mg/dL. What
is the FIRST action the practitioner should take? A) Administer the terlipressin via rapid IV bolus
to ensure immediate splanchnic vasoconstriction. B) Withhold the terlipressin and consult the
hepatologist, as efficacy is limited and risks outweigh benefits at this creatinine level. C)
Co-administer a high-dose albumin infusion (100g) rapidly to maximize oncotic pressure. D)
Prepare the client for immediate hemodialysis prior to terlipressin administration.
● The Answer: B (Withhold the terlipressin and consult the hepatologist, as efficacy is
limited and risks outweigh benefits at this creatinine level.)
● Distractor Analysis:
○ A is incorrect: Terlipressin is preferred as a continuous infusion to mitigate
respiratory failure, not a rapid bolus.
○ C is incorrect: High-dose albumin combined with terlipressin severely exacerbates
fluid overload and respiratory failure risk.
, ○ D is incorrect: Dialysis does not change the contraindication profile of terlipressin.
The Mentor's Analysis: The FDA label explicitly limits terlipressin use when baseline serum
creatinine is >5.0 mg/dL. At this threshold, renal recovery is highly unlikely, and the risk of fatal
respiratory failure from increased cardiac afterload is unjustified.
Q6: A 76-year-old client is scheduled for discharge. According to CDC/ACIP 2026/2027
guidelines, which statement regarding the RSV vaccine is MOST ACCURATE? A) "You will
need to receive this vaccine annually, alongside your influenza shot." B) "Because you received
the RSV vaccine last year, you are due for your booster today." C) "Since you are over 75, you
should receive a single lifetime dose; no booster is currently recommended." D) "The vaccine is
only indicated if you have a history of chronic obstructive pulmonary disease."
● The Answer: C ("Since you are over 75, you should receive a single lifetime dose; no
booster is currently recommended.")
● Distractor Analysis:
○ A is incorrect: RSV is currently not an annual vaccine.
○ B is incorrect: No boosters are recommended if the patient was previously
vaccinated.
○ D is incorrect: Age >=75 is a universal indication regardless of comorbidities.
The Mentor's Analysis: Do not conflate RSV protocols with influenza or COVID-19. The RSV
vaccine (Arexvy, Abrysvo, mResvia) provides sustained protection and is strictly a single-dose
administration for the 2026/2027 cycle.
Q7: Under Texas Board of Nursing Rule 217.11, a nurse refuses an assignment to float to the
neonatal intensive care unit (NICU), citing a lack of training and experience. The supervisor
threatens termination. Which principle STRICTLY protects the nurse's license in this scenario?
A) Rule 217.11(1)(B) regarding maintaining a safe environment supersedes employer directives.
B) The nurse cannot be terminated under the Texas At-Will Employment Doctrine. C) The
physician's order dictates staffing, nullifying the supervisor's threat. D) The nurse must accept
the assignment but file an incident report retroactively.
● The Answer: A (Rule 217.11(1)(B) regarding maintaining a safe environment supersedes
employer directives.)
● Distractor Analysis:
○ B is incorrect: The BON does not govern employment law; a nurse can be fired, but
their license is protected by refusing an unsafe assignment.
○ C is incorrect: Physicians do not dictate nursing assignments.
○ D is incorrect: Accepting an assignment you are incompetent to perform
immediately makes you liable for patient harm (Rule 217.11(1)(T)).
The Mentor's Analysis: Your license, your liability. The Board mandates you accept only
assignments commensurate with your education and ability. You must invoke Safe Harbor
before accepting the assignment. Employer threats do not shield you from Board discipline if a
patient dies under your incompetent care.
Q8: An APRN delegates the management of a complex, unstable patient on a titrated
vasoactive drip to a newly licensed LVN. According to Texas BON delegation rules, what is the
fundamental flaw in this action? A) Vasoactive drips must only be managed by physicians. B)
APRNs cannot assign tasks to LVNs that exceed the LVN's scope of practice, even with a
co-signature. C) The APRN failed to secure written consent from the patient for the delegation.
D) LVNs are strictly prohibited from working in intensive care units.
● The Answer: B (APRNs cannot assign tasks to LVNs that exceed the LVN's scope of
practice, even with a co-signature.)
● Distractor Analysis:
